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Abstract.  Propofol, known as “milk of anesthesia”, is used for the induction and maintenance of anesthesia. Recently, 
propofol has attracted increasing concerns about its safety and abuse potential because of its psychostimulant effects 
such as euphoria and sexual hallucinations. Previous reports focused on the effects of postoperative and neonatal 
exposure to propofol. However, the lasting effects of repetitive propofol administration during adulthood have not 
been well investigated. It is conceivable that prolonged use of propofol affects brain function and the behavioral 
characteristics of the abused patient. Thus, we performed a comprehensive behavioral analysis of mice exposed 
to propofol. Adult male C57BL/6J mice were repeatedly administered with propofol (20 or 80 mg/kg/day i.p.), 
intralipos (vehicle control), or saline only once a day for seven days. We then performed a behavioral test battery 
to evaluate various behaviors. Afterwards, we resumed the propofol treatment for three days and subsequently 
conducted contextual and cued fear conditioning tests. In the three‐chamber social approach test, propofol treatment 
attenuated social novelty preference in mice. In the fear conditioning test, high dose‐treated mice exhibited impaired 
long‐term cued‐dependent memory retention. In the rotarod test, propofol‐ and intralipos‐treated mice tended to 
have decreased motor coordination than the saline‐treated mice. Our results demonstrated that repetitive propofol 
treatment has the potential to induce some behavioral changes in mice. Additionally, the solvent itself might have 
effects different from that of propofol. Our findings provide basic data on the safe use and risk of propofol abuse.
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Highlights
Propofol, known as “milk of anesthesia”, has attracted increasing concerns about its safety and abuse potential. The 
lasting effects of repetitive propofol administration during adulthood have not been well investigated. To clarify the 
effects of repetitive propofol use on brain function and behavioral characteristics, we performed a comprehensive 
behavioral analysis of mice exposed to propofol. In this study, propofol treatment attenuated the social novelty 
preference and the performance of the cued long‐term memory task in mice. Additionally, treatment with propofol 
and intralipos tended to induce decreased motor coordination. Our results demonstrated that repetitive propofol 
treatment has the potential to induce some behavioral changes in mice. Furthermore, the solvent itself might have 
effects different from that of propofol. Our findings provide basic data for the safe use and risk of propofol abuse.
Introduction
Propofol is widely used for the induction and mainte‐
nance of anesthesia because of its rapid onset of action and 
short recovery time [1, 2]. Propofol enhances the action of 
γ‐Aminobutyric acid (GABA) through the GABA type A 
(GABAA) receptor and also blocks the N‐methyl‐D‐aspartate 
(NMDA) glutamate receptor [3]. Other than anesthesia, 
propofol has beneficial effects on human health. Previous 
reports showed the protective effects of propofol against 
ischemic injury of the adult brain and oxidative stress 
via GABAA receptor‐mediated signal cascade [4, 5]. Over 
the past ten years, propofol’s risk potential has received 
increased attention and was highlighted by the death of pop 
singer, Michael Jackson, in 2009 [6]. The misuse and abuse 
of propofol among healthcare providers have been reported 
worldwide, and some misuse has resulted in death [7, 8]. 
In the United States, 18% of anesthesiology departments 
reported one or more incidents of propofol abuse or diver‐
sion over the past 10 years [7]. These reports suggest that 
propofol can also have negative effects. The exact mecha‐
nisms and effects of propofol on brain function are not well 
understood. In fact, the memory loss after anesthesia using 
propofol has been reported as a side effect [9–11]. In some 
animal models, memory impairment by propofol treatment 
was demonstrated [12, 13]. These reports revealed the *Correspondence to: Takao, K.: takao@cts.u-toyama.ac.jp
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single‐dose and short‐term effects of propofol. However, 
the effect of repeated doses of propofol over the long‐term 
remains unclear. In addition, because of its poor solubility 
in water propofol is utilized as an emulsion contains soy oil 
and egg lecithin. In previous studies in rats, the contents of 
vehicles such as soy oil and egg lecithin induced anxiolytic 
behavior [14, 15]. These reagents may affect the results of 
experiments. Notably, some of the propofol studies have 
not been standardized by using saline as a control. In this 
study, we assessed the effects of four different solutions: 
saline, intralipos (solvent used as a vehicle), and low‐dose 
and high‐dose propofol. Therefore, in the present study, 
C57BL/6J mice treated repeatedly with propofol were 
evaluated using a comprehensive behavioral test battery 
to investigate how the repetitive use of propofol affects 
various behaviors.
Materials and Methods
animals and experimental design for comprehensive 
behavioral analysis
Fifty‐nine naïve male C57BL/6J mice were transported 
from Japan SLC, Inc. (Shizuoka, Japan) to the laboratory 
at University of Toyama when they were seven weeks old. 
After their arrival, they were group housed (4/cage) in a 
plastic cage (22.7 × 32.3 × 12.7 cm) in a room maintained 
at 24 ± 3°C with a 12‐hr light/dark cycle (lights on at 7:00 
am) and ad libitum access to food and water. The mice were 
randomly assigned to either the saline group (n=13), the 
intralipos group (n=14), the low‐dose (20 mg/kg) propofol 
group (n=16), or the high‐dose (80 mg/kg) propofol group 
(n=16). Propofol administration begun when the mice were 
eight weeks old. Their behaviors were assessed with a bat‐
tery of behavioral tests when the mice were nine weeks old.
Propofol treatment
Mice were treated with propofol (20 or 80 mg/kg, i.p.; 
Pfizer Inc., Tokyo, Japan) dissolved in intralipos (Otsuka 
Pharmaceutical Factory, Inc., Tokushima, Japan), intrali‐
pos only, or saline only (1% of body weight) once a day. 
Propofol treatment was initiated when the mice were eight 
weeks old and continued for seven days. To perform the 
fear conditioning test under the chronic treatment condi‐
tion, we resumed treatment three days before the test and 
interrupted treatment again after the test.
Behavioral tests
The mice were subjected to a battery of behavioral 
tests in the following sequence: general health and neuro‐
logic screening (body weight, body temperature, and grip 
strength), light/dark transition, open field, elevated plus 
maze, hot plate, social interaction, rotarod, three‐chamber 
social approach, startle response/prepulse inhibition, Porsolt 
forced swim test, and contextual/cued fear conditioning and 
fear extinction tests. The schedule for the comprehensive 
test battery for this study is shown in Table 1 and Fig. 1A. All 
the saline‐treated, intralipos‐treated, and propofol‐treated 
mice underwent the same test battery on the same day and 
in the same order. The ordinal position in the sequence of 
removal from the cage and the test chamber were carefully 
counterbalanced between groups. After each test, the floors 
and walls of the testing apparatuses were cleaned with 70% 
ethanol solution or super hypochlorous water to prevent 
bias caused by olfactory cues. The behavioral tests were 
performed between 8:30 am and 6:00 pm. Information about 
each mouse and the behavioral data collected in this study 
are available in the “Mouse Phenotype Database” (http://
www.mouse‐phenotype.org/).
General health and neurological screen test (GHNS):
The righting, whiskers twitch, and ear twitch reflexes 
were evaluated. A number of physical features, includ‐
ing the presence of whiskers or bald hair patches, were 
also recorded. Body weight and rectal temperature were 
measured. Neuromuscular strength was assessed using the 
grip strength and wire hang tests. A grip strength meter 
(O’Hara & Co., Tokyo Japan) was used to assess forelimb 
grip strength. In this test, mice were lifted and held by their 
tail while their forepaws grasped a wire grid. The mice 
were then gently pulled backward by the tail until they 
released their grip on the grid. The peak force applied by 
the forelimbs of the mouse was recorded in Newtons (N). 
Each mouse was tested three times, and the largest value 
was used for statistical analysis.
Light/dark transition test (LD):
The light/dark transition test, developed by Crawley and 
colleagues [16], was performed as previously described [17]. 
The apparatus comprised a cage (21 × 42 × 25 cm) divided 
into two sections of equal size by a partition with a door 
Table 1.  The schedule of the comprehensive behavioral test battery of propofol-treated mice
Order Test Age (w) Table/Figure
1 General health and neurological screen test (GHNS) 9 Table 2
2 Light/dark transition test (LD) 10 Table 2
3 Open-field test (OF) 10 Table 2
4 Elevated plus maze test (EP) 11 Fig. 3C–F
5 Hot plate test (HP) 11 Table 2
6 Social interaction test (SI) 11 Table 2
7 Rotarod test (RR) 12 Fig. 3A and 3B
8 Three-chamber social approach test (CSI) 13 Fig. 1C and 1D
9 Startle response/prepulse inhibition test (PPI) 14 Table 2
10 Porsolt forced swim test (PS) 14 Table 2
11 Contextual and cued fear conditioning and fear extinction test (FZ) 35–43 Fig. 2A–F, Table 2
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Fig. 1.  Propofol-treated mice exhibited abnormal social novelty in the three-chamber social approach test. The propofol treatment 
and the behavioral test battery were performed in the schedule as described above (A). Schematic diagram of the three-chamber 
social approach test (B). In the first session, one of the cages contains a stranger mouse (stranger 1), and the other cage is empty. In 
the second session, the test mouse becomes familiar with the stranger mouse (stranger 1), and the other stranger mouse (stranger 
2) is put in the other cage. The time spent around the cage with stranger 1 or around the empty cage, time spent around the cages 
with stranger 1 and stranger 2 (C), and total distance traveled (D) are shown. In the social novelty test, intralipos-treated mice showed 
more preference for stranger 2. On the other hand, there are no significant differences between preference for stranger 1 and 
stranger 2 in propofol-treated mice. Data are presented as means ± SEM for the indicated numbers of animals. The paired t-test (C) 
and one‐way analysis of variance (D) were used to test for statistical significance. The P values indicate the treatment effect in each 
statistical analysis. The asterisk indicates a nominally significant difference for comparisons between treatment groups (P<0.05) and 
the number sign indicates significance after Bonferroni correction (P<0.05/6).
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(O’Hara & Co.). One chamber was brightly illuminated (390 
lux), whereas the other was dark (2 lux). Mice were placed 
in the dark chamber and were allowed to move freely 
between the two chambers for 10 min with the door open. 
The distance traveled (cm), total number of transitions be‐
tween compartments, latency to the first entry into the light 
chamber (sec), and time spent in the light chamber (sec) 
were recorded automatically using the ImageLD program.
Open-field test (OF):
Locomotor activity was measured using an open‐field 
test. Each mouse was placed in the corner of the open‐field 
apparatus (40 × 40 × 30 cm: AccuScan Instruments, Colum‐
bus, OH, USA). The center of the floor was illuminated 
at 100 lux. Total distance traveled (cm), vertical activity 
(rearing measured by counting the number of photobeam 
interruptions), time spent in the center area (20 × 20 cm), and 
beam‐break counts for stereotypic behaviors were recorded. 
Data were collected for a period of 120 min.
Elevated plus maze test (EP):
The elevated plus maze test, which is widely used to 
assess anxiety‐like behavior, was performed as previously 
described [18]. The apparatus comprised two arms without 
walls (open arms, 25 × 5 cm), two arms of the same size 
with 15‐cm‐high transparent walls (closed arms), and a 
central square (5 × 5 cm) connecting the arms, which were 
at 90° to each other (O’Hara & Co.). The arms and central 
square were made of white plastic plates and were elevated 
to a height of 55 cm above the floor. The open arms were 
surrounded by a raised ledge (3 mm thick and 3 mm high) 
to prevent mice from falling off the open arms. Arms of the 
same type were located opposite one another. Each mouse 
was placed in the central square of the maze facing one 
of the closed arms. The number of arm entries, distance 
traveled (cm), percentage of entries into the open arms, and 
percentage of time spent in the open arms were measured 
during a 10‐min test period. Data acquisition and analysis 
were performed automatically using the ImageEP program.
Social interaction test (SI):
The social interaction test was conducted to measure 
social behavior in a novel environment, as previously de‐
scribed [19]. Weight‐matched (within 2 g) mice of the same 
treatment group that had been housed in different cages 
were placed together into an acrylic box (40 × 40 × 30 cm) 
and allowed to explore freely for 10 min. The total number 
of contacts, total duration of contacts (sec), total duration of 
active contacts (sec), mean duration per contact (sec), and 
total distance traveled (cm) were recorded and analyzed 
automatically using the ImageSI program. Active contact 
was defined as contact between two mice followed by one 
or both mice moving with a velocity of at least 10 cm/sec.
Three-chamber social approach test (CSI):
The three‐chamber social approach test is a well‐designed 
test to investigate sociability and preference for social nov‐
elty in mice [20]. The apparatus comprised a rectangular, 
three‐chambered box and a lid with a video camera (O’Hara 
& Co.). Each chamber was 20 × 40 × 47 cm, and the dividing 
walls were made from clear Plexiglas with a small square 
opening (5 × 3 cm) allowing access to each chamber. The 
tests were performed as previously described [21], with 
slight modification as follows: subject mice were placed 
in the three‐chambered box and allowed to explore for 10 
min before the sociability test was conducted (habituation 
session), and during the session, empty wire cages (9 cm in 
diameter, 11 cm in height, with vertical bars 0.5 cm apart) 
were located in the corner outside each compartment. 
During the following session, an unfamiliar C57BL/6J male 
mouse (stranger 1) that had had no prior contact with the 
subject mouse was put into a wire cage located in one of 
the side chambers. The location of the stranger mouse in 
the left vs right chamber was systematically alternated 
between trials. The subject mouse was placed in the central 
compartment and allowed to explore the entire box for 10 
min to assess sociability (sociability test). Next, a second 
stranger male mouse was placed into the wire cage in the 
other compartment that had been empty during the first 10‐
min session to evaluate social preference for a new stranger 
(social novelty preference test). Thus, the subject mouse had 
a choice between the first, already investigated and now 
familiar mouse (stranger 1) and the novel unfamiliar mouse 
(stranger 2). The amount of time spent in each chamber and 
time spent around each cage were automatically calculated 
from video images using the ImageCSI program. The male 
C57BL/6J mice used as stranger 1 and 2 were transported 
from Japan SLC, Inc. (Shizuoka, Japan) to the laboratory in 
University of Toyama when they were four weeks old. After 
their arrival, the mice were group housed (4/cage) and used 
for the three‐chamber social approach test when they were 
10–11 weeks old.
Rotarod test (RR):
Motor coordination and balance were tested with the 
rotarod test. The rotarod test was performed using an accel‐
erating rotarod (UGO Basile Accelerating Rotarod, Varese, 
Italy). It was performed by placing mice on a rotating drum 
(3 cm diameter) and measuring how long each animal was 
able to maintain its balance on the drum. The speed of the 
rotarod increased from 4 to 40 rpm over a 5‐min period.
Hot plate test (HP):
The hot plate test was used to evaluate sensitivity to a 
painful stimulus. The mice were placed on a 55.0 (± 0.3)°C 
hot plate (Columbus Instruments, Columbus, OH, USA), 
and the latency to the first hind‐paw response was recorded. 
The hind‐paw response was defined as either a foot shake 
or a paw lick.
Startle response/prepulse inhibition test (PPI):
The startle response and prepulse inhibition test were 
performed as previously described [22]. A startle reflex 
measurement system (O’Hara & Co.) was used. The mice 
were placed in a Plexiglas cylinder and left undisturbed for 
10 min. The test comprised two test trials involving only 
the startle stimulus, followed by four test trials for prepulse 
inhibition. White noise (40 msec) was used as the startle 
stimulus for all trials. The startle response was recorded for 
140 msec (while measuring the response every 1 msec) start‐
ing with the onset of the prepulse stimulus. The background 
noise level in each chamber was 70 dB. The peak startle 
amplitude recorded during the 140‐msec sampling window 
was used as the dependent variable. The intensity of the 
startle stimulus was 110 or 120 dB. The prepulse sound 
was presented 100 msec before the startle stimulus, and its 
intensity was 74 or 78 dB. Four combinations of prepulse 
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and startle stimuli were employed (74–110, 78–110, 74–120, 
and 78–120 dB). The mean inter‐trial interval was 15 sec 
(range 10–20 sec).
Porsolt forced swim test (PS):
The Porsolt forced swim test [23] was performed to as‐
sess depression‐related behavior. Mice were placed into a 
Plexiglas cylinder (20 cm height × 10 cm diameter, O’Hara 
& Co.) filled with water (approximately 23°C) up to a height 
of 7.5 cm for 10 min per day for two consecutive days. The 
percentage of time spent immobile was recorded automati‐
cally using the ImagePS program.
Contextual and cued fear conditioning test and extinction test 
(FZ):
The fear conditioning test was conducted using an auto‐
mated video‐analysis system as previously described [24]. 
Mice were placed in a conditioning chamber (26 × 34 × 29 
cm) in a sound‐attenuated room and allowed to explore 
freely for 2 min. The animals were presented with an audi‐
tory cue (55 dB white noise) that served as a conditioned 
stimulus (CS) for 30 sec. During the last 2 sec of the CS, 
mice were given a foot shock (0.3 mA, 2 sec) as an uncon‐
ditioned stimulus (US). Two more CS‐US pairings were 
presented at 120‐sec intervals. One day and 30 days after 
the conditioning session, a context test was performed in 
the conditioning chamber. A cued test in an altered context 
was performed after the context test using a triangular box 
(35 × 35 × 40 cm) made of white opaque plastic, which was 
located in a different sound‐attenuated room. In the cued 
test, after the initial 3‐min period of no CS presentation, the 
CS was presented during the last 3‐min period of the test. 
The cued tests were performed more than 30 min later after 
the contexts test were completed.
The fear extinction test was also conducted using an 
automated video‐analysis system 55 days after the condi‐
tioning session (Table 1). The animals were placed inside 
the conditioning chamber. After the initial 4‐min period 
of no cue presentation, the cue was presented during the 
last 14‐min period of the test. Next, mice were exposed to 
the altered context after the initial 3‐min period of no CS 
presentation, and the CS was presented during the last 
3‐min period of the test. Freezing during each minute of 
the test was measured automatically using the ImageFZ 
program in the same manner as previously described [24]
[23]. In the fear conditioning test, the data of one mouse 
from the saline group and two mice from the high‐dose 
group were excluded from statistical analysis because 
the mice died in the home cage before the test. In the fear 
extinction test, the data of another mouse were excluded 
from statistical analysis because it died in the home cage 
before the test. In addition, due to technical problems with 
the video analysis system, we failed to obtain the data for 
one mouse from the intralipos group, two mice from the 
low‐dose group, and one mouse from the high‐dose group, 
and therefore excluded the data for these mice from the 
statistical analysis.
data analysis in behavioral tests
Behavioral data were obtained automatically using 
applications (ImageLD [17], ImageEP [18], ImageSI [19], 
ImageCSI [21], ImagePS [25], and ImageFZ [24]) based 
on the public domain NIH Image program and ImageJ 
program. These applications were modified for each test. 
The plugins are freely available on the “Mouse Phenotype 
Database” website (http://www.mouse‐phenotype.org/
software.html) [26].
statistical analysis
Statistical analyses were performed using StatView (SAS 
Institute, Cary, NC, USA). A priori planned comparisons 
were performed to examine the effect of drug treatment 
(vehicle vs. propofol). In addition, we examined the effect 
of nutritive materials in the vehicle as a priori planned com‐
parisons (saline vs. vehicle). A priori planned multiple com‐
parisons were performed using the t‐test with Bonferroni 
correction. After a priori comparisons, data were analyzed 
using either the one‐way or two‐way analysis of variance 
(ANOVA) followed by Fisher’s Protected Least Significant 
Difference (PLSD) test, two‐way repeated measures ANO‐
VA, or paired t‐test, where appropriate. Values in graphs 
are presented as mean ± S.E.M. For multiple comparisons 
in the behavioral test battery, we defined study‐wide sig‐
nificance as statistical significance after controlling for the 
false discovery rate (FDR) [27, 28]. Nominal significance 
was defined as a statistically significant difference in an 
index (P<0.05) that did not survive FDR and Bonferroni 
corrections. For a priori multiple comparisons, P<0.05/3 was 
defined as statistically significant (2‐sided). For the post‐hoc 
multiple comparisons, P<0.05/6 was defined as statistically 
significant (2‐sided). The results of the statistical analyses 
are described in Table 2.
Results
abnormal social behavior in propofol-treated mice
We examined the social behavior of propofol‐treated 
mice using the social interaction test in a novel environment 
and the three‐chamber social approach test. In the social in‐
teraction test conducted in a novel environment, there were 
no significant differences among groups in all parameters 
(Table 2). The three‐chamber social approach test was used 
to assess sociability and social novelty preference. In the 
sociability test, the preference for a novel mouse is quanti‐
fied based on the time spent around a wire cage containing 
a stranger mouse versus an empty cage. In the social novelty 
preference test, the preference for a stranger mouse versus 
a familiar mouse is tested (Fig. 1B). In all four groups, the 
time spent around the cage with stranger 1 was significantly 
longer than the time spent around the empty cage (Fig. 1C). 
The total distance traveled by propofol‐treated mice sig‐
nificantly decreased compared with intralipos‐treated mice 
(treatment effect, P=0.0141; saline group vs intralipos group, 
P=0.0528; intralipos group vs low‐dose group, P=0.0038; 
intralipos group vs high‐dose group, P=0.0048; Fig. 1D). 
In the social novelty preference test, the intralipos‐treated 
mice spent a significantly longer time around the cage of 
the stranger mouse compared to that of the familiar mouse 
(Fig. 1C). In contrast, the other three groups did not show 
a significant preference for the stranger mouse (Fig. 1C). 
These results suggest that propofol treatment attenuated 
social novelty preference in mice.
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impaired performance of cued long-term memory 
task in propofol-treated mice
The cognitive functions of propofol‐treated mice were 
examined in a cued and contextual fear conditioning test. 
During conditioning, there was no significant difference 
in the levels of freezing among all groups (Fig. 2A). With 
the exception of the cued test performed 30 days after con‐
ditioning where differences in the levels of freezing were 
observed, there were no significant differences in the levels 
of freezing among all groups (Fig. 2B–D). In the cued test 
performed 30 days after conditioning, mice in the propofol 
group showed decreased levels of freezing than those in the 
other groups (pre‐CS; treatment effect, P=0.6951; treatment 
×time, P=0.1099; CS; treatment effect, P=0.0256; treatment 
×time, P=0.0393; intralipos group vs low‐dose group, 
P=0.0447; intralipos group vs high‐dose group, P=0.0044; 
Fig. 2E). The distance traveled by mice in all groups after the 
foot shocks were not significantly different among the treat‐
ment groups (Fig. 2F). Our findings suggest that repeated 
high‐dose propofol treatment impaired long‐term memory.
Effects of propofol treatment on other behaviors
There were no significant differences among the four 
groups of mice in terms of their physical characteristics 
(body weight and temperature) and muscle strength (grip 
strength and wire hang) (Table 2). In the first trial of the 
rotarod test, there was a significant difference among the 
groups (Treatment effect, P=0.0397; Fig. 3A and 3B). The 
high‐dose propofol‐treated mice showed decreased motor 
coordination compared to the saline group (saline group 
vs high‐dose group, P=0.0044; Fig. 3B). In addition, the 
trend in motor coordination was not different in the low‐
dose propofol‐ and intralipos‐treated mice (saline group 
vs low‐dose group, P=0.0715; saline group vs intralipos 
group, P=0.0947). In the elevated plus maze test, the treat‐
ment effect did not reach statistical significance. However, 
the saline group tended to spend a greater percentage of 
the time in the open arms compared to the other groups 
(saline group vs low‐dose group, P=0.0632; saline group 
vs high‐dose group, P=0.1616; saline group vs intralipos 
group, P=0.0442; Fig. 3F). The results obtained using the ro‐
tarod and elevated plus maze tests suggest that the solvent, 
intralipos, potentially causes deficits in motor coordination 
and increases anxiety‐like behavior in mice. There were no 
significant differences in behavior among groups in the 
other behavioral tests (Table 2).
Discussion and Conclusion
In the present study, mice that received repetitive propo‐
fol treatment underwent a comprehensive behavioral test 
battery to assess the effect of repeated use of the anesthetic 
agent on brain functions. Our findings revealed that the 
repeated administration of propofol reduced the preference 
for social novelty and impaired long‐term memory in the 
cued condition. There were no significant differences among 
the four groups in the other tests that were performed in 
this study (Table 2).
Propofol administration is suggested to affect social 
behavior. However, the effects appear to vary with the 
timing and duration of administration. In a previous report, 
repeated exposure of neonatal mice to propofol reduced 
sociability and social novelty preference in the three‐
chamber social approach test [29]. In our study, both low‐ 
and high‐dose propofol‐treated mice, and saline‐treated 
mice showed no significant preference for the stranger 
mouse (Fig. 1C). Our results suggested that the repetitive 
administration of propofol in adult mice may also induce 
a deficit in the preference for social novelty. In contrast, 
repeated propofol treatment did not affect sociability in our 
study. Another study showed that the single injection of 
adult mice with propofol did not induce any significant 
difference in social behaviors compared to control mice. 
Furthermore, in the same report, the impaired social 
preference in a mouse model of autism was improved by 
propofol treatment [30]. This report suggests that propofol 
treatment does not reduce, but rather improves sociability 
in adult mice. It is reported that when animals have an 
olfactory impairment, abnormal social behaviors can be 
observed in the three‐chamber social approach test since 
the mouse undergoing the test will need to identify the 
mouse in the wire cage based on olfactory cues [31]. In 
fact, some studies showed that propofol induces olfactory 
deficits [29, 32]. Furthermore, ventral hippocampus neurons 
are important for social memory [33]. It was reported that 
propofol affects synaptic transmission, neuron maturation, 
and neuron survival in the hippocampus [34, 35]. Consider‐
ing the reports of previous studies, the lack of preference for 
social novelty may be associated with the altered olfactory 
or hippocampus function.
Propofol administration induced impairments in the 
performance of a memory task. In studies involving 
animal models and human patients, the amnestic effects 
of propofol were described [2, 10, 11, 13]. These reports 
focused on the acute effect of propofol. Repeated propofol 
treatment during the neonatal and early postnatal periods 
induced neurotoxicity in the hippocampus and behavioral 
deficits during adulthood [12, 29, 36–38]. In our study, 
propofol‐treated mice showed decreased levels of freezing 
in the cued fear conditioning test (Fig. 2E). During the first 
4 min in all the cued tests, all groups of mice increased 
their freezing time even when no cue was presented. This 
phenomenon may be induced by fear generalization. In our 
study, the cued test was performed after the contextual test. 
Since mice were exposed to the fear‐conditioned context 
before the cued test, mice might have exhibited increased 
fear response even without the cue.‐However, there was no 
significant difference among the groups before the cue was 
presented. We, therefore, considered that the differences 
among the groups were based on the response to the CS. 
Our results suggested that propofol not only has acute ef‐
fects but also long‐lasting effects on memory function, and 
the effects are not restricted to the period of development. In 
the present study, propofol treatment affected cued, but not 
contextual, fear memory. Contextual associative learning is 
mediated by the hippocampus and amygdala [39]. On the 
other hand, cued associative learning is mediated mainly by 
the amygdala [40]. Previous studies showed propofol treat‐
ment effects on the hippocampus [12, 34, 35, 41]. However, 
in this study, propofol treatment affected the performance 
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Fig. 2.  High-dose propofol treatment impaired long-term memory in the cued fear conditioning test. The percentage of freezing time 
in the conditioning (A), context testing (B, D), and cued testing with altered context (C, E) conditions. Distance traveled following 
exposure to the three foot shocks during the conditioning phase was recorded (F). Mice in the propofol groups showed decreased 
levels of freezing compared to other groups during a cued test performed 30 days after conditioning. Data are presented as means 
± SEM for the indicated numbers of animals. The P values indicate the treatment effect in the one‐way repeated measures analysis of 
variance. In the cued test performed after 30 days, the asterisk indicates a nominally significant difference in 4‐6 min for comparisons 
between treatment groups (P<0.05) and the number sign indicates significance after Bonferroni correction (P<0.05/6).
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in the cued but not the contextual memory task. This result 
suggests that chronic propofol treatment influences the 
function of the amygdala. The GABAA receptor agonist, 
sevoflurane, blocks episodic memory in humans by reduc‐
ing connectivity between the amygdala and hippocampus 
[42]. Propofol is a GABAA receptor agonist and may act 
similarly to sevoflurane.
Propofol has a characteristic milky white appearance. 
It is prepared using a lipid emulsion because it is highly 
hydrophobic. This milky reagent is composed of soya oil, 
glycerol, and egg lecithin. As investigating propofol effects, 
these reagents injected into mice even these reagents may 
also affect mice behavior. However, in the previous pro‐
pofol studies, the control vehicles were not standardized, 
which may affect the results. To assess the effects separately, 
we compared the effects of treatments with four solutions: 
saline, intralipos (only milky regents), and low‐dose and 
high‐dose propofol. In the elevated plus maze test, the 
intralipos and propofol groups tended to be more anxious 
than the saline group (Fig. 3F). Furthermore, in the rotarod 
test, the latency to fall from the apparatus was shorter in 
the intralipos‐ and propofol‐treated mice compared to the 
saline‐treated mice in the first trial (Fig. 3A and 3B). In 
previous reports, the phytoestrogen content of soy oil and 
egg lecithin were shown to have anxiolytic effects in rats [14, 
15]. Though it is unknown which component causes these 
behavioral changes, our results suggested that intralipos, 
but not propofol, affects motor coordination and anxiety.
Although the mechanisms that underlie the behavioral 
responses induced by repeated propofol treatment require 
further investigation, the distinctive behavioral alterations 
observed in mice in this study provide basic data on the 
safe use of propofol, in order to avoid side effects following 
multiple exposure. This will encourage the proper use of 
propofol.
animal studies
All behavioral testing procedures were approved by the 
Institutional Animal Care and Use Committee of University 
of Toyama.
Fig. 3.  The results of the other behavioral tests. In the rotarod test, the latency to fall from the accelerating rotarod was measured in 
three trials per day (A). In the first trial, propofol‐treated mice showed shorter latency to fall (B). The elevated plus maze test: number 
of arm entries (C), distance traveled (D), percentage of entries into open arms (E), and percentage of time in open arms (F) are shown. 
Data are presented as means ± SEM for the indicated numbers of animals. The P values indicate a treatment effect in the one‐way 
analysis of variance (ANOVA) or repeated measures ANOVA. The asterisk indicates a nominally significant difference for comparisons 
between treatment groups (P<0.05) and the number sign indicates significance after Bonferroni correction (P<0.05/6).
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data repository
Raw data on the behavioral test and information about 
each mouse are accessible on the public database “Mouse 
Phenotype Database” (http://www.mouse‐phenotype.org/).
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